Global Industry Analyst | 309 pages | Août 2006 | Anglais
This report analyzes the worldwide markets for Anticoagulants in Millions of US$. The major product segments analyzed are Oral Anticoagulants and Injectable Anticoagulants(Unfractionated Heparin an ...
In 2007, blood diseases cost the USs economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white b ...
IntroductionDatamonitor expects the antihypertensives market to reach almost $40 billion, across the seven major markets, by 2016. The growth will be driven by the uptake of Novartis's Tekturna, as ...
IntroductionIncreased prevalence of diabetes, obesity, and cardiovascular disease, all causal factors of renal disease, drives growth of the end-stage renal disease (ESRD) sector. On average, an ES ...
IntroductionThe HRT market peaked in 2001 at $3.5 billion across the seven major markets. The Women's Health Initiative findings released in 2002 showing that HRT use was associated with an increas ...
The purpose of this report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by physicians to dia ...
The Cardiovascular Market Outlook to 2011 is a new report providing analysis of the current and future market for cardiovascular drugs across all major indications. Forecasts are given based on new ...
IntroductionThis analysis examines the historical and forecast performance for BMS in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline anal ...